CLINICAL OUTCOME OF VERY REFRACTORY HODGKIN'S LYMPHOMA

被引：0
|
作者：
Gaudio, F. [1 ]
Laddaga, F. E. [1 ]
Laddaga, F. E. [1 ]
Perrone, T. [1 ]
Perrone, T. [1 ]
Pinto, P. [1 ]
Leo, M. [1 ]
Bitetto, C. [1 ]
De Candia, M. S. [1 ]
Ingravallo, G. [2 ]
Pedote, P. [3 ]
Pastore, D. [1 ]
Specchia, G. [1 ]
机构：
[1] Univ Bari, Hematol, Bari, Italy
[2] Univ Bari, Patol, Bari, Italy
[3] Univ Bari, Radiol, Bari, Italy
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1776
引用
收藏
页码：704 / 704
页数：1
相关论文
共 50 条
  • [41] Outcome of elderly patients with classical Hodgkin's lymphoma
    Sykorova, A.
    Mocikova, H.
    Lukasova, M.
    Koren, J.
    Stepankova, P.
    Prochazka, V.
    Belada, D.
    Klaskova, K.
    Gaherova, L.
    Chroust, K.
    Buresova, L.
    Markova, J.
    LEUKEMIA RESEARCH, 2020, 90
  • [42] ESHAP as salvage therapy for relapsed or refractory Hodgkin’s lymphoma
    Jorge Labrador
    Mónica Cabrero-Calvo
    Estefanía Pérez-López
    María Victoria Mateos
    Lourdes Vázquez
    María Dolores Caballero
    Ramón García-Sanz
    Annals of Hematology, 2014, 93 : 1745 - 1753
  • [43] Trofosfamide is effective in refractory non-Hodgkin's lymphoma
    Salminen, E
    Nikkanen, V
    Lindholm, L
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (13-14) : 2419 - 2420
  • [44] Outcome of Refractory/Relapsing Pediatric Hodgkin Lymphoma at the National Cancer Institute, Egypt
    Ahmed, T.
    Rahman, H. Abdel
    El Zomor, H.
    Khorshed, E.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S195 - S195
  • [45] Spatial Tumor Microenvironment Characterization and Outcome of Relapsed/Refractory Classic Hodgkin Lymphoma
    Aoki, Tomohiro
    Jiang, Aixiang
    Xu, Alexander
    Gamboa, Alicia
    Yin, Yifan
    Milne, Katy
    Strong, Celia
    Goodyear, Talia
    Wu, Shaocheng
    Chong, Lauren C.
    Takata, Katsuyoshi
    Chavez, Elizabeth
    Miyata-Takata, Tomoko
    Colombo, Anthony R.
    Hav, Monirath
    Telenius, Adele
    Ben-Neriah, Susana
    Weng, Andrew P.
    Savage, Kerry J.
    Scott, David W.
    Roth, Andrew
    Farinha, Pedro
    Nelson, Brad H.
    Merchant, Akil
    Steidl, Christian
    BLOOD, 2022, 140
  • [46] Retrospective analysis of 20 cases of refractory Hodgkin's lymphoma
    Yang, H. L.
    Zhang, Y. Z.
    Jiang, Y. Z.
    Wang, X. F.
    Cao, Z.
    NEOPLASMA, 2017, 64 (06) : 933 - 937
  • [47] ESHAP AS SALVAGE THERAPY FOR RELAPSED OR REFRACTORY HODGKIN'S LYMPHOMA
    Labrador, J.
    Cabrero-Calvo, M.
    Perez-Lopez, E.
    Lopez-Corral, L.
    Mateos, M.
    Sanchez-Guijo, F.
    Vazquez, L.
    Bastida, J.
    Lopez-Godino, O.
    Lopez-Parra, M.
    San Miguel, J.
    Caballero, M.
    Garcia-Sanz, R.
    HAEMATOLOGICA, 2013, 98 : 69 - 69
  • [48] Treatment of refractory and relapsed Hodgkin's lymphoma: facts and perspectives
    Brusamolino, Ercole
    Carella, Angelo Michele
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (01): : 6 - 10
  • [49] ESHAP as salvage therapy for relapsed or refractory Hodgkin's lymphoma
    Labrador, Jorge
    Cabrero-Calvo, Monica
    Perez-Lopez, Estefania
    Victoria Mateos, Maria
    Vazquez, Lourdes
    Dolores Caballero, Maria
    Garcia-Sanz, Ramon
    ANNALS OF HEMATOLOGY, 2014, 93 (10) : 1745 - 1753
  • [50] Can we cure refractory Hodgkin's lymphoma with transplantation?
    Ciurea, Stefan O.
    Kongtim, Piyanuch
    Srour, Samer
    Saini, Neeraj
    Im, Jin
    Ramdial, Jeremy
    Khouri, Issa
    Anderlini, Paolo
    Popat, Uday
    Hosing, Chitra
    Champlin, Richard E.
    Lee, Hun J.
    Fayad, Luis E.
    Hagemeister, Fredrick B.
    Bica, Ana M.
    Lipan, Lavinia
    Craciun, Oana
    Jercan, Cristina G.
    Tanase, Alina
    Colita, Anca
    BONE MARROW TRANSPLANTATION, 2021, 56 (01) : 278 - 281
12345